DiaMedica Therapeutics (DMAC) earnings: expect negative EPS

11:45 am ET, 12 May 2019

DiaMedica Therapeutics (DMAC) is announcing earnings on May 13 after the market closes. We combed through analyst estimates to understand what the company revenue and earnings are predicted to look like.

What should you expect from the upcoming earnings?

Earnings per share are expected to come in at $-0.22.

How did the stock do last month?

Over the last month, DiaMedica Therapeutics (DMAC) returned -15.84%.

For the latest price and information on DiaMedica Therapeutics, please visit Finstead and ask for "DMAC", "DMAC analysis" or "DMAC news".

Powered by Froala Editor

DiaMedica Therapeutics (DMAC) Stock Guide

Updated at: 5:49 am ET, 05 Sep 2020

Before we start: if you're looking for DMAC stock price, you can quickly find it out by visiting Finny and typing "DMAC quote". If you're looking for a quick scoop on DMAC stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for "DMAC". You'll get all this info in one place. Or you can just type "DMAC news" to get the latest stock news.

Looking to buy or sell DiaMedica Therapeutics (DMAC)? Interested in getting the full scoop on DMAC, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place.

In this DMAC stock guide, we'll address key questions about DMAC, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar.

Here is what you'll be able to find in this guide:

Earnings and Dividends: earnings, earnings date, dividend rate and dividend yield;
Analysis: Finny Score and buy or sell analysis;
Key Stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio, industry, sector, and number of employees.

And here is the list of questions we'll answer:
1. What are DMAC earnings?
2. DMAC buy or sell? What is DMAC Finny Score?
3. What are the reasons to buy DMAC? Why should I buy DMAC stock?
4. What are the reasons to sell DMAC? Why should I sell DMAC stock?
5. What are DMAC key stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

So let's start. Scroll down to the question that interests you the most.

Earnings and Dividends

1. What are DMAC earnings?

DMAC trailing 12-month earnings per share (EPS) is -$0.77.

Analysis

2. DMAC buy or sell? What is DMAC Finny Score?

#{finnyScore:null}Our quantitative analysis shows 1 reason to buy and 1 reason to sell DMAC. DMAC doesn’t have an assigned Finny Score, because we don’t have sufficient data points to score the stock.

3. What are the reasons to buy DMAC? Why should I buy DMAC stock?

Here are the reasons to buy DMAC stock:

  • DMAC cash to debt ratio is 79.72, higher than the average industry (0.16) and sector (0.16) cash to debt ratio. See DMAC cash to debt chart.

4. What are the reasons to sell DMAC? Why should I sell DMAC stock?

Let's look at the reasons to sell DMAC stock (i.e., the bear case):

Key Stats

5. What are DMAC key stats : revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

Let's look at the key statistics for DMAC:

Metrics DMAC
Price $4.58
Average Price Target / Upside N/A
Average Analyst Rating N/A
Forward Dividend Yield 0.00%
Industry Biotechnology
Sector Healthcare
Number of Employees 11
Market Cap $84.51M
Forward P/E Ratio N/A
Price/Book Ratio N/A
Revenue (TTM) N/A
YoY Quarterly Revenue Growth N/A
Profit Margin 0.00%

If you liked this analysis, check out Stock Guides for other stocks.

Follow Us